Viewing Study NCT04048135


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2026-01-24 @ 7:19 PM
Study NCT ID: NCT04048135
Status: COMPLETED
Last Update Posted: 2024-04-02
First Post: 2019-08-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
Sponsor: 89bio, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NASH View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NASH, NAFLD View
None Liver diseases View
None Fatty Liver View
None Metabolic diseases View